94.0%
metformininsulinDPP-4 inhibitorsGLP-1 inhibitorssulfonylureasSGLT2 inhibitorsMitochondrial cytopathiesdiabetesNeuroscience Research Australiachronic kidney disease+1 more
…th diabetes (n=23), 14 (60.9%) are on insulin, 9 (39.1%) are on metformin, 7 (30.4%) are on SGLT2 inhibitors,5 (14.7%) are on sulfonylure…